Umbilical Cord Procalcitonin to Detect Early-Onset Sepsis in Newborns: A Promising Biomarker
Open Access
- 10 December 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 9, 779663
Abstract
Background: Up to 7% of neonates born in high-income countries receive antibiotics for suspected early-onset sepsis (EOS). Culture-proven neonatal sepsis has a prevalence of 0.2%, suggesting considerable overtreatment. We studied the diagnostic accuracy of umbilical cord blood and infant blood procalcitonin (PCT) in diagnosing EOS to improve antibiotic stewardship.Methods: Umbilical cord blood PCT was tested in newborns ≥ 32 weeks of gestation. Groups were defined as following: A) culture-proven or probable EOS (n = 25); B) Possible EOS, based on risk factors for which antibiotics were administered for n = 49); C) Risk factor(s) for EOS without need for antibiotic treatment (n = 181); D) Healthy controls (n = 74). Additionally, venous or capillary blood PCT and C-reactive protein (CRP) were tested if blood drawing was necessary for standard care.Results: Between June 2019 and March 2021, 329 newborns were included. Umbilical cord blood PCT was significantly higher in group A than in group C and D. No difference between venous or arterial samples was found. Sensitivity and specificity for cord blood procalcitonin were 83 and 62%, respectively (cut-off 0.1 ng/mL). Antepartum maternal antibiotic administration was associated with decreased PCT levels in both cord blood and infant blood directly postpartum in all groups combined.Conclusion: Umbilical cord blood PCT levels are increased in newborns ≥32 weeks with a proven or probable EOS and low in newborns with risk factors for infection, but PCT seems not a reliable marker after maternal antibiotic treatment. PCT could be useful to distinguish infected from healthy newborns with or without EOS risk factors.Keywords
This publication has 28 references indexed in Scilit:
- Neonatal sepsisThe Lancet, 2017
- Early and Late Infections in Newborns: Where Do We Stand? A ReviewPediatrics & Neonatology, 2016
- Application of sepsis calculator in newborns with suspected infectionThe Journal of Maternal-Fetal & Neonatal Medicine, 2016
- Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance studyThe Lancet Infectious Diseases, 2014
- Cord blood procalcitonin and Interleukin-6 are highly sensitive and specific in the prediction of early-onset sepsis in preterm infantsScandinavian Journal of Clinical and Laboratory Investigation, 2014
- Stratification of Risk of Early-Onset Sepsis in Newborns ≥34 Weeks’ GestationPediatrics, 2014
- Umbilical cord blood procalcitonin level in early neonatal infections: a 4-year university hospital cohort studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Use of Procalcitonin-Guided Decision-Making to Shorten Antibiotic Therapy in Suspected Neonatal Early-Onset Sepsis: Prospective Randomized Intervention TrialNeonatology, 2009
- Procalcitonin as an early marker of infection in neonates and childrenThe Lancet Infectious Diseases, 2004
- Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infantsThe Pediatric Infectious Disease Journal, 1999